Riccardo Canevari was appointed Chief Commercial Officer of Advanced Accelerator Applications (AAA), a Novartis company in March 2020. Prior to this, Riccardo was Senior Vice President & Global Head, Breast Cancer Franchise, for Novartis Oncology since 2017.
As Franchise Head, Riccardo led global strategy and execution in the top nine markets for the global breast cancer franchise. He was also responsible for overseeing the launch of major breast cancer products, including KISQALI and PIQRAY.
From 2013 to 2017, Riccardo served as General Manager and Country President Greece for Novartis Pharma. In this role, he oversaw 500 associates in five business franchises, generating $600 million in sales. During this period, he maintained business continuity during a major financial crisis in Greece, achieving a best-in-class market penetration despite a volatile economic environment.
Prior to this, Riccardo was General Manager and Cluster Head for Novartis Pharma, leading a group of 10 Eastern European countries generating approximately $100 million in sales. During his tenure from 2011 to 2013, he delivered 7 percent top-line growth for the business and new product sales rose from 17 percent to 40 percent in 24 months through improved access, reimbursement and launch of new brands.
From 2005 to 2011, Riccardo served in country Business Head and Sales Force Head roles in Italy for Novartis Pharma and Ethicon, a Johnson & Johnson company. Before this, he held several Brand Manager positions with increasing responsibility at the Menarini Group, Novartis Pharma, and Novartis Oncology.
Riccardo holds a University degree in Pharmacy, Chemistry and Pharmaceutical Technologies from University of Pavia, Italy. He has also completed Executive Education coursework in marketing, finance, general management and leadership from the Wharton School of the University of Pennsylvania, Columbia Business School and Harvard Business School.